XML 25 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income (loss) $ (21,006) $ 70,015 $ (56,696)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Amortization and depreciation 7,027 7,103 7,019
Amortization of debt issuance costs 217 264 264
Restricted stock and stock option expense 6,774 4,221 3,452
Deferred federal income taxes (8,268) 11,783 (19,554)
Amortization of bond premium and discount, net 6,957 4,887 5,925
Net realized investment (gains) losses 14,662 (35,342) 16,907
Loss on extinguishment of debt 3,060 0 0
Loss from equity method investments, net of distributions 6,346 0 0
Changes in:      
Premiums receivable, net 8,604 (30,356) (3,293)
Reinsurance receivables, net (4,770) 30,480 (9,358)
Funds held by ceding insurers 4,294 928 (5,791)
Unpaid losses and loss adjustment expenses 32,630 (49,850) 45,367
Unearned premiums (23,366) 32,949 (3,485)
Ceded balances payable (11,461) 5,410 4,143
Other assets and liabilities (8,240) (16,162) 46,823
Contingent commissions (1,096) 1,292 2,652
Federal income tax receivable/payable 10,989 (123) (534)
Deferred acquisition costs 5,482 (9,001) (29)
Prepaid reinsurance premiums 3,835 3,878 8,257
Net cash provided by operating activities 32,670 32,376 42,069
Cash flows from investing activities:      
Proceeds from sale of fixed maturities 791,554 977,321 293,348
Proceeds from sale of equity securities 604,772 260,891 35,639
Proceeds from maturity of fixed maturities 119,326 180,546 55,182
Proceeds from other invested assets 4,211 16,757 43,377
Amounts received (paid) in connection with derivatives (20,456) (7,654) 4,392
Purchases of fixed maturities (808,618) (1,129,567) (370,536)
Purchases of equity securities (455,907) (365,255) (36,258)
Purchases of other invested assets (60,297) (13,283) (16,309)
Acquisition of business 0 0 (3,515)
Net cash provided by (used for) investing activities 174,585 (80,244) 5,320
Cash flows from financing activities:      
Net borrowings (repayments) under margin borrowing facility (73,629) 7,811 (6,412)
Dividends paid to common shareholders (14,252) (14,222) (14,027)
Distributions paid to preferred shareholders (133) 0 0
Issuance of series A cumulative fixed rate preferred shares 4,000 0 0
Purchases of class A common shares 153 947 1,867
Redemption of subordinated notes 100,000 0 0
Net cash used for financing activities (184,167) (7,358) (22,306)
Net change in cash and cash equivalents 23,088 (55,226) 25,083
Cash and cash equivalents at beginning of period 44,271 99,497 74,414
Cash and cash equivalents at end of period $ 67,359 $ 44,271 $ 99,497